TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ENGN

enGene Holdings Inc.

Healthcare · Biotechnology

2.00$ +0.5% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ENGN
Line item 2020 2021 2022 2023 2024 2025
– – – – – –
– – – – +84.6% +57.6%
– – – – – –
– +17.4% +24.1% +6.4% +132.8% +146.6%
– -2.6% +3.3% +159.8% +183.1% +19.6%
– +14.6% +22.4% +34.1% +139.1% +97.7%
– – – – – –
– +35.8% -71.7% +248.1% -43.5% +7.0%
– – – – – –
– +12.9% -99.6% -22.7% -211.8% –
– – – – – –
– – – – – –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?